Convened by Carnstone and designed and delivered by Schneider Electric, Energize will help pharmaceutical and healthcare suppliers to address their own operational Scope 2 greenhouse gas emission through renewable electricity procurement, which will in turn reduce the participating companies’ Scope 3 emissions. Energize will enable suppliers to learn more about renewable energy adoption and contracting, giving them an opportunity to participate in the market for Power Purchase Agreements (PPAs).
The programmes corporate supporters include Sustainable Healthcare Coalition members AstraZeneca and Johnson and Johnson, alongside other pharma industry majors, Biogen, GSK, MSD, Novartis, Novo Nordisk, Pfizer, Sanofi, and Takeda. All ten pharmaceutical companies have committed to engaging their suppliers to support the adoption of renewable energy and reduce greenhouse gas emissions within their supply chains. Creating life-saving medicines and services requires a lot of energy, much of it being used by the value chain. By proactively engaging with their suppliers to create renewable energy opportunities, the 10 convening companies are taking meaningful action to collectively address their energy usage and inspire other industry sectors to follow suit.
More information on the programme.